BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3780980)

  • 1. Lack of adenosine deaminase deficiency in the mutant mouse wasted.
    Geiger JD; Nagy JI
    FEBS Lett; 1986 Nov; 208(2):431-4. PubMed ID: 3780980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine deaminase activity in recipients of bone marrow from immunodeficient mice homozygous for the wasted mutation.
    Willis EH; Carson DA; Shultz LD
    Biochem Biophys Res Commun; 1987 May; 145(1):581-5. PubMed ID: 3297058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of adenosine deaminase in the wasted mouse.
    Abbott CM; Skidmore CJ; Searle AG; Peters J
    Proc Natl Acad Sci U S A; 1986 Feb; 83(3):693-5. PubMed ID: 3456164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.
    Schrader WP; Pollara B; Meuwissen HJ
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):446-50. PubMed ID: 24216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of normal and mutant forms of human adenosine deaminase - a review.
    Daddona PE; Kelley WN
    Mol Cell Biochem; 1980 Feb; 29(2):91-101. PubMed ID: 6988697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
    Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
    J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficient-severe combined immunodeficiency.
    Ratech H; Hirschhorn R
    Clin Chim Acta; 1981 Sep; 115(3):341-7. PubMed ID: 6975191
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease.
    Carson DA; Goldblum R; Keightley R; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():463-70. PubMed ID: 855722
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adenosine deaminase activity and immune dysfunction (author's transl)].
    Bremer H; Bauer I; Brock J
    Allerg Immunol (Leipz); 1981; 27(1):3-13. PubMed ID: 6455054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenosine deaminase deficiency in primary immunodeficiencies (author's transl)].
    Belohradsky BH; Hennig N; Marget W; Fudenberg HH
    Klin Wochenschr; 1976 Dec; 54(23):1109-15. PubMed ID: 1003869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase deficiency in combined immunologic deficiency disease.
    Meuwissen HJ; Pickering RJ; Pollara B
    Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
    Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
    J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal platelet aggregation in severe combined immunodeficiency disease with adenosine deaminase deficiency.
    Schwartz AL; Polmar SH; Stern RC; Cowan DH
    Br J Haematol; 1978 Jun; 39(2):189-94. PubMed ID: 678472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
    Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH
    J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother.
    Schmalstieg FC; Mills GC; Tsuda H; Goldman AS
    Pediatr Res; 1983 Dec; 17(12):935-40. PubMed ID: 6606796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.
    Valerio D; Duyvesteyn MG; van Ormondt H; Meera Khan P; van der Eb AJ
    Nucleic Acids Res; 1984 Jan; 12(2):1015-24. PubMed ID: 6198631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase and nucleoside phosphorylase activity in patients with immunodeficiency syndromes.
    Chen SH; Ochs HD; Scott CR; Giblett ER
    Clin Immunol Immunopathol; 1979 Jun; 13(2):156-60. PubMed ID: 110506
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of iron deficiency anemia on development of thymus and spleen and adenosine deaminase activity in rats].
    Luo C; Chen J; Liao Q; Li Q; Yang X; Li Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1990 Mar; 21(1):63-6. PubMed ID: 2365344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic molecular defect in ADA-SCID.
    Herbschleb-Voogt E; Scholten JW; Vossen JM; Pearson PL; Meera Khan P
    Adv Exp Med Biol; 1984; 165 Pt A():381-4. PubMed ID: 6720406
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
    Polmar SH
    Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.